Table 3 Cox proportional hazards regression model for factors influencing progression-free and overall survival
From: FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
Variable | Hazard ratio (95% confidence interval (CI)) | χ 2 | P- value |
|---|---|---|---|
Progression-free survival | |||
Gender (male vs female) | 0.7 (0.3–1.8) | 0.6 | 0.43 |
Age | 1.0 (1.0–1.0) | 0.0 | 0.93 |
T stage | 1.5 (0.9–2.4) | 2.7 | 0.10 |
N stage | 1.4 (0.9–2.0) | 2.6 | 0.11 |
Incomplete metabolic response | 4.1 (1.5–11.5) | 6.2 | 0.013 |
Overall survival | |||
Gender (male vs female) | 0.6 (0.2–1.8) | 1.0 | 0.32 |
Age | 1.0 (1.0–1.1) | 0.4 | 0.52 |
T stage | 1.6 (0.9–2.7) | 3.0 | 0.09 |
N stage | 1.5 (1.0–2.3) | 9.0 | 0.08 |
Incomplete metabolic response | 6.7 (2.1–21.6) | 9.2 | 0.002 |
